- Home
- NEON vs IGC Comparison
NEON vs IGC Comparison
Compare NEON & IGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NEON
- IGC
- Stock Information
- Founded
- NEON 1997
- IGC 2005
- Country
- NEON Sweden
- IGC United States
- Employees
- NEON N/A
- IGC N/A
- Industry
- NEON Industrial Machinery/Components
- IGC Biotechnology: Pharmaceutical Preparations
- Sector
- NEON Technology
- IGC Health Care
- Exchange
- NEON Nasdaq
- IGC Nasdaq
- Market Cap
- NEON 56.4M
- IGC 39.8M
- IPO Year
- NEON 2007
- IGC N/A
- Fundamental
- Price
- NEON $3.21
- IGC $0.38
- Analyst Decision
- NEON Hold
- IGC Strong Buy
- Analyst Count
- NEON 1
- IGC 2
- Target Price
- NEON $6.00
- IGC $4.00
- AVG Volume (30 Days)
- NEON 645.0K
- IGC 767.6K
- Earning Date
- NEON 11-05-2025
- IGC 11-11-2025
- Dividend Yield
- NEON N/A
- IGC N/A
- EPS Growth
- NEON N/A
- IGC N/A
- EPS
- NEON N/A
- IGC N/A
- Revenue
- NEON $2,605,000.00
- IGC $1,327,000.00
- Revenue This Year
- NEON N/A
- IGC $3.54
- Revenue Next Year
- NEON $43.34
- IGC $15.12
- P/E Ratio
- NEON N/A
- IGC N/A
- Revenue Growth
- NEON N/A
- IGC 24.95
- 52 Week Low
- NEON $3.13
- IGC $0.25
- 52 Week High
- NEON $29.90
- IGC $0.50
- Technical
- Relative Strength Index (RSI)
- NEON 23.90
- IGC 39.96
- Support Level
- NEON $3.13
- IGC $0.36
- Resistance Level
- NEON $3.45
- IGC $0.43
- Average True Range (ATR)
- NEON 0.19
- IGC 0.02
- MACD
- NEON 0.55
- IGC -0.00
- Stochastic Oscillator
- NEON 11.80
- IGC 23.65
About NEON Neonode Inc.
Neonode Inc provides optical sensing solutions for contactless touch, and gesture sensing and also provides software solutions for machine perception that feature machine learning algorithms to detect and track persons and objects in video streams from cameras and other types of imagers. It markets and sells its solutions to customers in many different markets and segments including, but not limited to, office equipment, automotive, industrial automation, medical, military, and avionics. The company geographically operates in the United States, Japan, South Korea, Germany, Sweden, China, and other regions. A majority of its revenue is generated from Japan.
About IGC IGC Pharma Inc.
IGC Pharma Inc develops cannabinoid-based formulations for treating diseases and conditions, including, but not limited to, Alzheimer's disease, period cramps, premenstrual syndrome, and chronic pain. The company has investigational drug assets targeting Alzheimer's disease, IGC-AD1, IGC-M3, IGC-1C, and TGR-63, which have demonstrated in Alzheimer's cell lines the potential to be effective in suppressing or ameliorating key hallmarks of Alzheimer's disease, such as plaques or tangles.